AVE avecho biotechnology limited

elixir,, page-6

  1. ACB
    4,958 Posts.
    I think the strategy is smart....there are less hurdles, time and costs in going down the cosmetic path even if it doesn't produce a "company making" outcome...if it becomes cashflow positive as a result it means less dilution when the big deal does come along with Nestle, CSL or the like

    cosmetics does not preclude in any way the company-making deals for drug delivery, it's in addition to that market

    I also think the name is okay
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $14.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $26.59K 6.419M

Buyers (Bids)

No. Vol. Price($)
13 7711400 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 20942354 23
View Market Depth
Last trade - 15.22pm 16/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.